2024 Annual Meeting | C173 - Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia
Program Materials Program Evaluations
03:30 PM - 04:05 PM MDT | Speaker |
Non-pharmacological Treatments in Dementia
Julio C. Rojas-Martinez, MD, PhD |
04:05 PM - 04:40 PM MDT | Speaker |
Pharmacological Treatments in Dementia
Lealani M. Acosta, MD, MPH, FAAN |
04:40 PM - 05:15 PM MDT | Speaker |
Disease Modifying Treatments in Dementia
Meredith Wicklund, MD, FAAN |
05:15 PM - 05:30 PM MDT | Q&A |
Questions & Answers
Meredith Wicklund, MD, FAAN, Julio C. Rojas-Martinez, MD, PhD, Lealani M. Acosta, MD, MPH, FAAN |
Meredith Wicklund, MD, FAAN | The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH. |
Julio C. Rojas-Martinez, MD, PhD | The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. Dr. Rojas-Martinez has received research support from Roon, Healthcare. The institution of Dr. Rojas-Martinez has received research support from Amylyx. |
Lealani M. Acosta, MD, MPH, FAAN | Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Biohaven, Roche, NIH. |